TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ENTA

Enanta Pharmaceuticals Inc

Healthcare · Biotechnology

13.00$ +0.9% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

Enanta Pharmaceuticals Inc (ENTA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -19 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ENTA
Line item 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-10 24 23 11 20 77 36 53 29 71 7.1 -70 -85 -103 -79 -19
0.6 0.5 0.2 0.2 0.4 0.6 1.7 2.1 2.5 3.3 3.6 3.3 3.0 2.4 2.3 5.1
0.3 0.2 0.4 1.1 2.7 5.8 9.4 13 16 19 20 21 27 28 27 19
– – – -1.2 -14 14 4.8 10 17 10 26 19 27 – – –
-18 -2.4 0.1 0.7 -2.3 -17 6.2 22 -62 11 13 -14 6.8 8.0 7.1 40
0.0 0.4 0.3 0.6 1.0 2.3 4.7 2.5 3.0 5.4 1.4 0.8 2.1 9.1 18 13
1.7 -18 -18 -69 0.5 -88 -44 -4.6 -35 -87 20 37 55 -54 58 40
– – – 0.0 0.0 0.0 0.0 0.0 0.0 2.7 – – – – – –
– – – 57 1.1 2.5 1.0 -0.2 -1.8 -4.2 -1.5 -0.5 -1.2 -3.8 – –
– – – – -0.1 -0.1 -0.1 -0.1 -0.1 -0.1 – – 0.0 0.0 -27 –
0.0 0.0 -0.9 57 1.2 2.5 2.7 1.0 4.4 2.6 9.0 3.1 20 198 -28 -27
-8.5 6.4 3.7 -1.7 22 -9.0 -5.1 49 -1.8 -13 36 -30 -9.9 41 -48 -5.5
-10 24 22 10 19 74 31 50 26 66 5.6 -71 -87 -112 -97 -32

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?